HT-3 It is All in the Eye of the Beholder - What is the Ideal Clinical Outcome Study?
CE: 1.0
The field of endodontics offers decades of endodontic treatment and volumes of outcome studies. Are these outcome studies valid? What are their deficiencies? What will be required for future outcome studies? How does the specialty of endodontics compare with other dental and non-dental specialties? Are we missing critical outcome measures that may lead to a revision in our definition of success? Drawing on medicine and other fields of dentistry, this presentation will summarize critical issues in defining clinical outcomes and treatment success.
At the conclusion, participants should be able to:
- Describe differences in clinical outcomes as defined by various endodontic stakeholders.
- Apply these concepts for evaluating endodontic clinical trials.
- Describe a process for defining and validating clinical outcome measures.
Kenneth Hargreaves, D.D.S., Ph.D.
Ken Hargreaves received his DDS from Georgetown University, his PhD in physiology from the Uniformed Services University of the Health Sciences in Bethesda, MD, and his certificate in Endodontics from the University of Minnesota. Ken spent 5 years at the Pain Clinic of the NIDCR and 7 years as an associate professor of Endodontics and Pharmacology at the University of Minnesota. He joined the University of Texas Health Science Center at San Antonio in 1997, as professor and Chair of the Department of Endodontics and is cross-appointed as professor in the Departments of Pharmacology, Physiology and Surgery in the Medical School. He maintains a private practice limited to endodontics and is a Diplomate of the American Board of Endodontists. Ken has received an NIH MERIT Award for research, two IADR Distinguished Scientist Awards, the ADA Gold Medal for Research and the Louis I. Grossman Award from the AAE. He has published more than 190 articles and, with Harold Goodis and Frank Tay, co-edited the 2nd edition Seltzer and Bender’s Dental Pulp, and, with Lou Berman, co-edited the 11th edition of Cohen’s Pathways of the Pulp. Ken also serves as editor of the Journal of Endodontics.
Speaker Disclosure:
I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation
Kenneth M. Hargreaves, D.D.S., Ph.D.
I declare that I have proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.Vindolor (Self) : CSO (Status: Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Status: Ongoing)
